Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/19/11 → 7/19/17 |
Funding
- Aptiv Solutions (Prot # ICT-107-201 // Prot # ICT-107-201)
- ImmunoCellular Therapeutics, Ltd. (Prot # ICT-107-201 // Prot # ICT-107-201)
Prot # ICT-107-201: A Randomized, Double-blind, Controlled Phase IIb Study of the Safety and Efficacy of ICT-107 in Newly Diagnosed Patients with Glioblastoma Multiforme (GBM) Following Resection and Chemoradiation
- Chandler, James P (PD/PI)
- Raizer, Jeffrey J (Co-Investigator)
Project: Research project